Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-1b) (PROTECT)

June 9, 2023 updated by: Ji Xunming,MD,PhD, Capital Medical University

Effect of Ischemic Post-conditioning on Infarct Volume in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy

Ischemic post-conditioning is a neuroprotective strategy attenuating reperfusion injury in animal stroke models. The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy. This study aims to assess the infarct volume after ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Tianjin, China, 300350
        • Recruiting
        • Tianjin Huanhu Hospital
        • Contact:
          • Ming Wei, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 years;
  • Acute ischemic stroke within 24 hours from stroke onset (or from time last known well) to groin puncture;
  • Previous mRS ≤ 2;
  • Baseline NIHSS ≥ 6;
  • Baseline ASPECTS ≥ 6;
  • With an occlusion of unilateral middle cerebral artery M1 segment/distal intracranial carotid artery;
  • Successful recanalization (mTICI ≥ 2b) after thrombectomy confirmed by DSA;
  • Written informed consent provided by the patients or their legal relatives.

Exclusion Criteria:

  • Confirmed or clinically suspected cerebral vasculitis/fibromuscular dysplasia;
  • Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
  • Stenting in the middle cerebral artery M1 segment/distal intracranial carotid artery during thrombectomy;
  • > 2 times balloon dilations as rescue therapy due to angioplasty during thrombectomy;
  • Moderate/severe residual stenosis (≥ 50%) in the offending artery after thrombectomy;
  • Patients with contraindications to MRI;
  • Other conditions that the investigator considered inappropriate for inclusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ischemic post-conditioning group
Mechanical thrombectomy combined with ischemic post-conditioning
Ischemic post-conditioning will be applied after successful recanalization of the culprit artery by thrombectomy. Ischemic post-conditioning consists of briefly repeated four cycles × 2 minutes of occlusion and reperfusion (equal duration) of the initially occluded artery using a balloon.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infarct volume
Time Frame: 72 hours after procedure
Infarct volume at 72 hours after procedure
72 hours after procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The progression of infarct volume
Time Frame: Baseline and 72 hours after procedure
Difference of infarct volume between baseline and 72 hours after procedure
Baseline and 72 hours after procedure
National Institute of Health Stroke Scale (NIHSS) score
Time Frame: 24 hours after procedure
NIHSS score at 24 hours after procedure; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
24 hours after procedure
The proportion of early neurological improvement
Time Frame: 24 hours after procedure
NIHSS 0-2 or ≥8 lower than baseline NIHSS score at 24 hours after procedure; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
24 hours after procedure
NIHSS score at 7 days after procedure/discharge
Time Frame: 7 days after procedure/discharge
NIHSS score at 7 days after procedure/discharge; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
7 days after procedure/discharge
Recanalization rate
Time Frame: 24 hours after procedure
Recanalization rate at 24 hours after procedure (mTICI ≥2b)
24 hours after procedure
The proportion of functional independence at 90 days
Time Frame: 90 days after procedure
The modified Rankin Scale (mRS) score of 0-2 at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
90 days after procedure
The proportion of favorable outcome at 90 days
Time Frame: 90 days after procedure
The mRS score of 0-3 at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
90 days after procedure
The distribution of the mRS score at 90 days
Time Frame: 90 days after procedure
The distribution of the mRS score at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
90 days after procedure
Hemodynamic assessment
Time Frame: Within 24 hours after procedure
Hemodynamic assessment within 24 hours after procedure
Within 24 hours after procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety outcome (mortality at 90 days)
Time Frame: 90 days after procedure
90-day mortality
90 days after procedure
Procedure-related complications
Time Frame: During the procedure
Vascular perforation/rupture, vessel dissection, severe vasospasm, rupture of the balloon used for post-conditioning
During the procedure
Safety outcome (the proportion of symptomatic intracranial hemorrhage within 24 hours)
Time Frame: Within 24 hours after procedure
The proportion of symptomatic intracranial hemorrhage within 24 hours after procedure
Within 24 hours after procedure
Safety outcome (the proportion of intracranial hemorrhage within 24 hours)
Time Frame: Within 24 hours after procedure
The proportion of intracranial hemorrhage within 24 hours after procedure
Within 24 hours after procedure
Safety outcome (the proportion of malignant brain edema within 24 hours)
Time Frame: Within 24 hours after procedure
The proportion of malignant brain edema within 24 hours after procedure
Within 24 hours after procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Estimated)

December 31, 2023

Study Completion (Estimated)

March 31, 2024

Study Registration Dates

First Submitted

June 9, 2023

First Submitted That Met QC Criteria

June 9, 2023

First Posted (Estimated)

June 19, 2023

Study Record Updates

Last Update Posted (Estimated)

June 19, 2023

Last Update Submitted That Met QC Criteria

June 9, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reperfusion Injury

Clinical Trials on Mechanical thrombectomy combined with ischemic post-conditioning

3
Subscribe